TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Takara Bio Inc. ( (JP:4974) ) is now available.
Takara Bio Inc. has completed the absorption-type merger of its wholly owned subsidiary, ViSpot, Inc., as part of its strategy to streamline management and accelerate business growth. The merger, effective May 1, 2025, is expected to have a minor impact on the company’s consolidated business performance.
More about Takara Bio Inc.
Takara Bio Inc. operates in the biotechnology industry, focusing on the manufacturing and sales of reagents and instruments, contract development and manufacturing organization (CDMO) services, and gene therapy business. The company is headquartered in Kusatsu, Shiga, Japan.
YTD Price Performance: -19.27%
Average Trading Volume: 337,351
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen100.1B
For detailed information about 4974 stock, go to TipRanks’ Stock Analysis page.